SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193805-18-000480
Filing Date
2018-03-29
Accepted
2018-03-29 17:22:00
Documents
2
Period of Report
2018-03-27

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT e617861_4-homology.html 4  
1 OWNERSHIP DOCUMENT e617861_4-homology.xml 4 6947
2 e617861_ex99.htm EX-99 4481
  Complete submission text file 0001193805-18-000480.txt   13492
Mailing Address 780 THIRD AVENUE, 37TH FLOOR NEW YORK NY 10017
Business Address 780 THIRD AVENUE 37TH FLOOR NEW YORK NY 10017 2125511600
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (Reporting) CIK: 0001009258 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 001-38433 | Film No.: 18724008

Mailing Address 780 THIRD AVENUE 37TH FLOOR NEW YORK NY 10017
Business Address
Flynn James E (Reporting) CIK: 0001352546 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38433 | Film No.: 18724009

Mailing Address 45 WIGGINS AVE. BEDFORD MA 01730
Business Address 45 WIGGINS AVE. BEDFORD MA 01730 857-305-1825
Homology Medicines, Inc. (Issuer) CIK: 0001661998 (see all company filings)

IRS No.: 473468154 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences